NeuroOne Medical Tech Analyst Ratings
NeuroOne Medical Tech Analyst Ratings
| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 08/15/2023 | 105.61% | Alliance Global Partners | $3.25 → $2.2 | Maintains | Buy |
| 03/28/2022 | — | Craig-Hallum | Downgrades | Buy → Hold | |
| 12/03/2021 | 437.38% | Alliance Global Partners | → $5.75 | Initiates Coverage On | → Buy |
| 11/15/2021 | 460.75% | Craig-Hallum | → $6 | Initiates Coverage On | → Buy |
| 日期 | 上行/下行 | 分析公司 | 目標價格變化 | 評級變化 | 上一次/當前評級 |
|---|---|---|---|---|---|
| 2023年08月15日 | 105.61% | 聯盟全球合作夥伴 | $3.25→$2.2 | 維護 | 買 |
| 03/28/2022 | - | 克雷格-哈勒姆 | 評級下調 | 購買→Hold | |
| 12/03/2021 | 437.38% | 聯盟全球合作夥伴 | →$5.75 | 開始承保 | →購買 |
| 2021年11月15日 | 460.75% | 克雷格-哈勒姆 | →$6 | 開始承保 | →購買 |
What is the target price for NeuroOne Medical Tech (NMTC)?
NeuroOne Medical Tech(NMTC)的目標價格是多少？
The latest price target for NeuroOne Medical Tech (NASDAQ: NMTC) was reported by Alliance Global Partners on August 15, 2023. The analyst firm set a price target for $2.20 expecting NMTC to rise to within 12 months (a possible 105.61% upside). 1 analyst firms have reported ratings in the last year.
聯盟全球合作夥伴於2023年8月15日報道了NeuroOne Medical Tech(納斯達克：nmtc)的最新目標價。這家分析公司將目標價定為2.2美元，預計NMTC將在12個月內上漲至(可能上漲105.61%)。1家分析公司在過去一年公佈了評級。
What is the most recent analyst rating for NeuroOne Medical Tech (NMTC)?
NeuroOne Medical Tech(NMTC)的最新分析師評級是多少？
The latest analyst rating for NeuroOne Medical Tech (NASDAQ: NMTC) was provided by Alliance Global Partners, and NeuroOne Medical Tech maintained their buy rating.
分析師對NeuroOne Medical Tech(納斯達克代碼：NMTC)的最新評級由Alliance Global Partners提供，NeuroOne Medical Tech維持買入評級。
When is the next analyst rating going to be posted or updated for NeuroOne Medical Tech (NMTC)?
NeuroOne Medical Tech(NMTC)的下一次分析師評級將於何時發佈或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of NeuroOne Medical Tech, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for NeuroOne Medical Tech was filed on August 15, 2023 so you should expect the next rating to be made available sometime around August 15, 2024.
分析師在進行了廣泛的研究後得出了股票評級，其中包括查閱公共財務報表，與NeuroOne Medical Tech的高管和客戶交談，以及聽取收益電話會議。大多數分析師每三個月就會這樣做一次，所以你每年應該會得到每家公司每家公司的4個評級。NeuroOne Medical Tech的上一次評級是在2023年8月15日提交的，所以你應該預計下一次評級將在2024年8月15日左右提供。
Is the Analyst Rating NeuroOne Medical Tech (NMTC) correct?
分析師對NeuroOne Medical Tech(NMTC)的評級正確嗎？
While ratings are subjective and will change, the latest NeuroOne Medical Tech (NMTC) rating was a maintained with a price target of $3.25 to $2.20. The current price NeuroOne Medical Tech (NMTC) is trading at is $1.07, which is out of the analyst's predicted range.
雖然評級是主觀的，並將發生變化，但最新的NeuroOne Medical Tech(NMTC)評級保持不變，目標價在3.25美元至2.20美元之間。NeuroOne Medical Tech(NMTC)目前的交易價格為1.07美元，超出了分析師的預測區間。